{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:10:54Z","timestamp":1781104254826,"version":"3.54.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Secondary prophylaxis of rheumatic heart diseases is efficient in reducing disease recurrence, heart damage, and cardiac impairment. We aimed to monitor the clinical evolution of a large Brazilian cohort of rheumatic patients under prolonged secondary prophylaxis. From 1986 to 2018, a cohort of 593 patients with rheumatic fever was followed every 6 months by the Reference Center for the Control and Prevention of Rheumatic Fever and Rheumatic Cardiopathy (CPCFR), Paran\u00e1, Brazil. In this cohort, 243 (41%) patients did not present cardiac damage (group I), while 350 (59%) were diagnosed with rheumatic heart disease (RHD) (group II) using the latest case definition. Among group II, 233 and 15 patients had impairment of the mitral and aortic valves, respectively, while 102 patients had impairment of both valves. Lesions on the mitral and aortic valves presented a regression in 69.9 and 48.7% of the patients, respectively. Active patient recruitment in the reference center and early detection of oropharyngeal GAS were important factors for optimal adherence to the prophylactic treatment. Patients with disease progression were associated with noncompliance to secondary prophylaxis. No patients undergoing regular prophylaxis presented progression of the rheumatic cardiac disease. Eighteen valvular surgeries were performed, and four (0.7%) patients died. This study confirmed that tailored and active efforts invested in rheumatic heart disease secondary prevention allowed for significant clinical improvement.<\/jats:p>","DOI":"10.3389\/fcvm.2021.676098","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T04:41:40Z","timestamp":1624423300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis"],"prefix":"10.3389","volume":"8","author":[{"given":"Renato Pedro de Almeida","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f4mulo Francisco de Almeida","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle de","family":"Crombrugghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarllet Palacin","family":"Moraes da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Leticia Veroneze","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Alessandra","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre R.","family":"Smeesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros\u00e2ngela Stadnick Lauth de Almeida","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5935\/abc.20170068","article-title":"Analysis of the economic impact of cardiovascular diseases in the last five years in brazil","volume":"109","author":"Siqueira","year":"2017","journal-title":"Arqu Brasil Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5935\/abc.20190141","article-title":"Rheumatic fever: a Disease without color","volume":"113","author":"Figueiredo","year":"2019","journal-title":"Arqu Brasil Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group a streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","article-title":"Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the american heart association rheumatic fever, endocarditis, and kawasaki disease committee of the council on cardiovascular disease in the young, the interdisciplinary council on functional genomics and translational biology, and the interdisciplinary council on quality of care and outcomes research: endorsed by the american academy of pediatrics","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of group a Streptococcal pharyngitis: 2012 Update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0002-8703(64)90132-2","article-title":"The prognosis of acute rheumatic fever","volume":"68","author":"Feinstein","year":"1964","journal-title":"Am Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/01.CIR.45.3.543","article-title":"Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin","volume":"45","author":"Tompkins","year":"1972","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0895-4356(92)90070-4","article-title":"Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report","volume":"45","author":"Majeed","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the american heart association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease\u2013an evidence-based guideline","volume":"9","author":"Remenyi","year":"2012","journal-title":"Nat Rev Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ejechocard\/jeq030","article-title":"European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Europ J Echocard."},{"key":"B14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Europ J Echocard."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","article-title":"Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-Income countries","volume":"134","author":"Z\u00fchlke","year":"2016","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/tmi.12796","article-title":"Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in fiji","volume":"21","author":"Engelman","year":"2016","journal-title":"Trop Med Int Health."},{"key":"B17","first-page":"73","article-title":"Estudo de 500 casos de febre reum\u00e1tica na cidade de curitiba","volume":"19","author":"Torres","year":"2000","journal-title":"Divulg sa\u00fade debate"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e003498","DOI":"10.1161\/JAHA.116.003498","article-title":"Rheumatic heart disease severity, progression and outcomes: a Multi\u2010 state model","volume":"6","author":"Cannon","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S0482-50042012000200008","article-title":"Rheumatic fever presentation and outcome: a case-series report","volume":"52","author":"Carvalho","year":"2012","journal-title":"Rev Brasil Reumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1136\/heartjnl-2015-308237","article-title":"Newly diagnosed rheumatic heart disease among indigenous populations in the pacific","volume":"101","author":"Mirabel","year":"2015","journal-title":"Heart."},{"key":"B21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12872-016-0344-x","article-title":"Sharing success\u2013understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease","volume":"16","author":"Chamberlain-Salaun","year":"2016","journal-title":"BMC Cardiovascular Disorders."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e010223","DOI":"10.1161\/JAHA.118.010223","article-title":"How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease","volume":"7","author":"de Dassel","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13063-016-1166-y","article-title":"Improving delivery of secondary prophylaxis for rheumatic heart disease in remote indigenous communities: study protocol for a stepped-wedge randomised trial","volume":"17","author":"Ralph","year":"2016","journal-title":"Trials."},{"key":"B24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ajr.12379","article-title":"Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in far north queensland","volume":"26","author":"Haran","year":"2018","journal-title":"Austral J Rural Health."},{"key":"B25","first-page":"301","article-title":"Natural history of rheumatic heart disease, a 12 years observational study \u201cpenicillin bites the muscle but heals the heart","volume":"26","author":"Rizvi","year":"2014","journal-title":"J Ayub Med Coll Abbottabad."},{"key":"B26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/0974-2069.99610","article-title":"Prognostic value of clinical and doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease","volume":"5","author":"Ara\u00fajo","year":"2012","journal-title":"Ann Pediatr Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.676098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T04:41:43Z","timestamp":1624423303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.676098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2021.676098"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.676098","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"article-number":"676098"}}